Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
Document Type
Journal Article
Publication Date
2-17-2020
Journal
JAMA Neurology
DOI
10.1001/jamaneurol.2019.5125
APA Citation
Howard, J. F., Nowak, R. J., Wolfe, G. I., Freimer, M. L., Vu, T. H., Hinton, J. L., Benatar, M., Duda, P. W., MacDougall, J. E., Farzaneh-Far, R., Kaminski, H. J., Barohn, R., Dimachkie, M., Pasnoor, M., Farmakidis, C., Liu, T., Colgan, S., Benatar, M. G., Bertorini, T., Pillai, R., Henegar, R., Bromberg, M., Gibson, S., Janecki, T., Freimer, M., Elsheikh, B., Matisak, P., Genge, A., Guidon, A., David, W., Habib, A. A., Mathew, V., Mozaffar, T., Hinton, J. L., Hewitt, W., Barnett, D., Sullivan, P., Ho, D., Howard, J. F., Traub, R. E., Chopra, M., Kaminski, H. J., Aly, R., Bayat, E., Abu-Rub, M., Khan, S., Lange, D., Holzberg, S., Khatri, B., Lindman, E., Olapo, T., Sershon, L. M., Lisak, R. P., Bernitsas, E., Jia, K., Malik, R., Lewis-Collins, T. D., Nicolle, M., Nowak, R. J., Sharma, A., Roy, B., Nye, J., Pulley, M., Berger, A., Shabbir, Y., Sachdev, A., Patterson, K., Siddiqi, Z., Sivak, M., Bratton, J., Small, G., Kohli, A., Fetter, M., Vu, T., Lam, L., Harvey, B., Wolfe, G. I., Silvestri, N., Patrick, K., Zakalik, K., Duda, P. W., MacDougall, J., Farzaneh-Far, R., Pontius, A., & Hoarty, M. (2020). Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.. JAMA Neurology, (). http://dx.doi.org/10.1001/jamaneurol.2019.5125
Peer Reviewed
1
Comments
Online ahead of print